Harper Tanton will be the fourth child in the world to participate in the clinical trial for kids who have CTNNB1 syndrome. She largely depends on a wheelchair and has developmental and speech delays.
She has an ultra-rare disease. Now this N.S. girl will be one of the first to test a possible cure
Aug 4, 2026 | 5:00 AM
